BDBM725076 (R)-5-(tert-butyl)-N-(1-(4- (2- (cyclopropanecarboxamido) pyridin-4-yl)-2- (trifluoromethyl)phenyl) ethyl)-1,2,4-oxadiazole-3- carboxamide::US12240838, Compound 78

SMILES C[C@@H](NC(=O)c1noc(C(C)(C)C)n1)c1ccc(-c2ccnc(NC(=O)C3CC3)c2)cc1C(F)(F)F

InChI Key InChIKey=UJRPLUGVISIDJX-UHFFFAOYSA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 725076   

TargetTyrosine-protein kinase BTK(Human)
Biogen Ma

US Patent
LigandPNGBDBM725076((R)-5-(tert-butyl)-N-(1-(4- (2- (cyclopropanecarbo...)
Affinity DataIC50: 1nMAssay Description:The purpose of the BTK in vitro assay is to determine compound potency against BTK through the measurement of IC50. Compound inhibition is measured a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/6/2025
Entry Details
US Patent